KU Hematology & Medical Oncology Review 2019
P

KU ASCO 2019 Head and Neck Update: New Standard for Recurrent and Metastatic Disease "Incurable" and Salivary Duct Carcinoma

By KU Hematology & Medical Oncology Review 2019 FEATURING Prakash Neupane
By KU Hematology & Medical Oncology Review 2019 FEATURING Prakash Neupane
940 views
August 21, 2019
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
18:07
Nebraska Oncology Society

NOS ASCO® 2023 Review: Nasopharynx Cancer

Feat. E. Sherman
13:06
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Key H&N Cancer Studies Including FRAIL…

Feat. P. Bossi
12:02
Insights from 2023 IFHNOS Annual Meeting

IFHNOS 2023 Insights: "Personalized (Precision) Medicine in Hea…

Feat. C. Stratakis
26:51
Paolo Bossi

Year in Review: Head & Neck Cancers

14:56
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Key H&N Cancer Updates"

Feat. P. Bossi
23:38
2023 West Oncology Conference

Improving the Quality of Life for Head & Neck Cancer Survivors: …

Feat. B. Murphy
06:11
ecancer

ASCO® 2023 Insights: "Key Head & Neck Data"

Feat. G. Hanna
54:42
UNC Lineberger Comprehensive Cancer Center

2023 UNC Head and Neck Cancer Management Updates

Feat. J. Weiss, S. Sheth, W. Yarbrough, C. Shen
04:33
GRACE

Treatment Options for Patients With Head & Neck Cancer and High …

Feat. J. Weiss
04:46
GRACE

Emerging Treatment Options for Head and Neck Cancer

Feat. J. Weiss
33:08
Northwell Health

Salivary Gland Tumors: Overview of Diagnosis and Management

Feat. A. Hines
19:57
Michael Gibson

AHNS 2023 Insights: "HNSCC Updates - Tumor Microenvironment, Ne…

06:27
Insights from 2023 ASCO® Annual Meeting

Enfortumab Vedotin in the Previously Treated Advanced Head & Nec…

Feat. P. Swiecicki
47:34
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Fred Hutchinson Cancer Center Head & Neck Cancer Updates

Feat. C. Rodriguez
10:16
ESMO 2022 Conference Coverage

ESMO 2022 H&N Updates

Feat. N. Saba
22:27
Nebraska Oncology Society

NOS ASCO® 2023 Review: Head & Neck Cancer De-Escalation

Feat. E. Sherman
08:09
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "AIM-HN Study Evaluating Tipifarnib in mHRA…

Feat. A. Ho
03:48
GRACE

Treatment of Recurrent/Metastatic HPV+ SCCHN

Feat. J. Weiss
08:36
i3 Health

Recurrent and Metastatic HNSCC: New Insights and Real-World Evidence…

Feat. A. Sacco
02:34
Dana-Farber Cancer Institute

ESMO 2023 Insights: "AIM-HN Study - Evaluating Tipifarnib in mH…

Feat. R. Haddad